Hoomans Ties, Evers Silvia M A A, Ament André J H A, Hübben Mariette W A, van der Weijden Trudy, Grimshaw Jeremy M, Severens Johan L
Department of Health Organisation, Policy, and Economics, Maastricht University, Maastricht, The Netherlands.
Value Health. 2007 Jul-Aug;10(4):305-16. doi: 10.1111/j.1524-4733.2007.00175.x.
Despite the emphasis on efficiency of health-care services delivery, there is an imperfect evidence base to inform decisions about whether and how to develop and implement guidelines into clinical practice. In general, studies evaluating the economics of guideline implementation lack methodological rigor. We conducted a systematic review of empiric studies to assess advances in the economic evaluations of guideline implementation.
The Cochrane Effective Professional and Organisational Change Group specialized register and the MEDLINE database were searched for English publications between January 1998 and July 2004 that reported objective effect measures and implementation costs. We extracted data on study characteristics, quality of study design, and economic methodology. It was assessed whether the economic evaluations followed methodological guidance.
We included 24 economic evaluations, involving 21 controlled trials and three interrupted time series designs. The studies involved varying settings, targeted professionals, targeted behaviors, clinical guidelines, and implementation strategies. Overall, it was difficult to determine the quality of study designs owing to poor reporting. In addition, most economic evaluations were methodologically flawed: studies did not follow guidelines for evaluation design, data collection, and data analysis.
The increasing importance of the value for money of providing health care seems to be reflected by an increase in empiric economic evaluations of guideline implementation. Because of the heterogeneity and poor methodological quality of these studies, however, the resulting evidence is still of limited use in decision-making. There seems to be a need for more methodological guidance, especially in terms of data collection and data synthesis, to appropriately evaluate the economics of developing and implementing guidelines into clinical practice.
尽管强调医疗服务提供的效率,但在决定是否以及如何制定和实施临床实践指南方面,仍缺乏完善的证据基础。总体而言,评估指南实施经济学的研究缺乏方法上的严谨性。我们对实证研究进行了系统综述,以评估指南实施经济评估方面的进展。
检索Cochrane有效专业和组织变革小组专门注册库以及MEDLINE数据库,查找1998年1月至2004年7月期间报告客观效果指标和实施成本的英文出版物。我们提取了关于研究特征、研究设计质量和经济方法的数据。评估经济评估是否遵循方法学指导。
我们纳入了24项经济评估,涉及21项对照试验和3项中断时间序列设计。这些研究涉及不同的环境、目标专业人员、目标行为、临床指南和实施策略。总体而言,由于报告不佳,难以确定研究设计的质量。此外,大多数经济评估在方法上存在缺陷:研究未遵循评估设计、数据收集和数据分析的指南。
提供医疗服务性价比的重要性日益增加,这似乎反映在指南实施实证经济评估的增加上。然而,由于这些研究的异质性和方法学质量较差,所得证据在决策中的用途仍然有限。似乎需要更多的方法学指导,特别是在数据收集和数据综合方面,以适当地评估将指南制定和实施到临床实践中的经济学。